BDNF and GSK-3β signaling in depression: molecular mechanisms underlying neural plasticity dysfunction
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12110-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 08.07.2026. Verfasst von Hayder M Al-Kuraishy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Medicine, Medical Faculty, College of Medicine, Al-Mustansiriyah University, PO Box 14132, Baghdad, Iraq. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Neuronal Plasticity, Brain-Derived Neurotrophic Factor, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 179 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Depression, a complicated psychiatric condition, is characterized by persistent low mood, disrupted emotional regulation, and cognitive impairment. Attenuated brain-derived neurotrophic factor (BDNF) and dysregulated glycogen synthase kinase-3 beta (GSK-3β) activity promote synaptic deterioration, oxidative imbalance, neuroinflammatory responses, and hippocampal dysfunction, hallmark features of depressive pathology. This review provides an overview of current preclinical and clinical findings explaining the independent and interactive roles of BDNF and GSK-3β in depression. It further illustrates emerging therapeutic approaches targeting this axis, such as metformin, famotidine, tideglusib, lithium, and ketamine. Collectively, the altered crosstalk between BDNF and GSK-3β contributes to the impaired neuroplasticity observed in depression, suggesting that this signaling axis is a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology and Medicine, Medical Faculty, College of Medicine, Al-Mustansiriyah University, PO Box 14132, Baghdad, Iraq.
- Department of Biochemistry, Faculty of Pharmacy, Kaferelsheikh University, Kaferelsheikh, Egypt. shimaa_abass@pharm.kfs.edu.eg.
- College of Pharmacy, Al-Farahidi University, Baghdad, 10021, Iraq. shimaa_abass@pharm.kfs.edu.eg.
- Faculty of Veterinary Medicine, Damanhour University, AlBeheira, Damanhour, 22511, Egypt.
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, AlBeheira, Damanhour, 22511, Egypt. dr_gaber_batiha@vetmed.dmu.edu.eg.
Zitieren
APA
Al-Kuraishy, H. M., Abass, S. A., Mahana, H. A. M., Elbanna, O. A., Shahin, I. Y., Radwan, A. A., MohamedMohamed, O. E., Baktoot, A. M. L., & Batiha, G. E. (2026). BDNF and GSK-3β signaling in depression: molecular mechanisms underlying neural plasticity dysfunction. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12110-4
Vancouver
Al-Kuraishy HM, Abass SA, Mahana HAM, Elbanna OA, Shahin IY, Radwan AA, et al. BDNF and GSK-3β signaling in depression: molecular mechanisms underlying neural plasticity dysfunction. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12110-4
BibTeX
@article{AlKuraishy2026,
author = {Al-Kuraishy, Hayder M and Abass, Shimaa A and Mahana, Hitham Alaa Mohammed and Elbanna, Osama Ashraf and Shahin, Ibrahiym Yasser and Radwan, Abdelrahman Ali and MohamedMohamed, Omar El-Sayed and Baktoot, AbdAlRhman Mohamad Lotfy and Batiha, Gaber El-Saber},
title = {BDNF and GSK-3β signaling in depression: molecular mechanisms underlying neural plasticity dysfunction},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12110-4}
}
EUVIMED